This project aims to provide treatment for 1045 thalassemia patients across Sindh province. Each patient needs a blood transfusion every 2 weeks, leading to high levels of iron in their body. Iron chelation therapy once a month is essential to manage iron overload, a common complication of the disease. This therapy helps prevent organ damage and improves the overall quality of life for patients.
Thalassemia, a genetic blood disorder in Pakistan, According to NIH, it affects up to 7% of the population, with over 10 million carriers and 5000 new cases of thalassemia major annually. This condition reduces hemoglobin production, causing anemia. Patients often need regular blood transfusions, leading to iron overload and organ damage such as the heart, liver, and endocrine glands . Iron chelation therapy is used to manage this excess iron, preventing complications.
To provide comprehensive treatment for thalassemia patients across country, addressing a critical need for regular blood transfusions and iron chelation therapy. By ensuring access to these essential treatments, the project will significantly improve the quality of life for thalassemia patients, reduce complications associated with iron overload, and ultimately enhance their overall health outcomes. Additionally, the project will raise awareness about thalassemia which is very Important.
This project includes improved quality of life for 1045 thalassemia patients, reduced healthcare costs, and increased awareness about thalassemia and iron chelation therapy. By effectively managing iron overload, the project can prevent organ damage and complications, leading to better health outcomes for patients. Additionally, increased awareness can lead to earlier diagnosis and treatment, further improving outcomes and reducing the overall burden of thalassemia individual.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser
